Evidence map›Paper›PMID 42232379›Full record

ArticleJournal of family & community medicine

Trend and predictive modeling of hypertension risk using multiyear community health surveillance data: Evidence from 2019 to 2021.

Johannes B Ginting, Tri Suci, Chrismis N Ginting, Kristiawan Indriyanto

Abstract read
In one paragraph

Article in Journal of family & community medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Johannes B GintingDepartment Master of Public Health, Faculty of Medicine, Dentistry and Health Sciences, Prima University, North Sumatra, Indonesia.
Tri SuciDepartment Master of Public Health, Faculty of Medicine, Dentistry and Health Sciences, Prima University, North Sumatra, Indonesia.
Chrismis N GintingDepartment Master of Public Health, Faculty of Medicine, Dentistry and Health Sciences, Prima University, North Sumatra, Indonesia.
Kristiawan IndriyantoDepartment Master of Indonesia Language Education, Faculty of Teacher Teaching and Education, Prima University, North Sumatra, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypertension remains a major global health burden, often undetected until complications occur. In Indonesia, evidence integrating multiyear surveillance data with machine learning (ML) to predict population-level risk remains limited. The objective of the study was to examine temporal trends in hypertension risk and develop predictive models at the population level. MATERIALS AND

methodsThis observational study utilized community health surveillance data on 196,951 adults (2019-2021). Blood pressure was classified using World Health Organization/Joint National Committee 7 criteria, with prehypertension and hypertension combined as abnormal (

resultsAbnormal blood pressure prevalence increased from 74.4% (2019) to 79.7% (2020) and 80.2% (2021). XGBoost demonstrated superior performance, achieving 78.3% accuracy and an area under the curve of 0.736, outperforming other models. SHAP analysis identified age, waist circumference, body mass index, and male sex as the strongest predictors of the risk of hypertension.

conclusionHypertension risk in Indonesia rose from 2019 to 2021. Interpretable ML models, particularly XGBoost, show potential for population-level risk stratification and early detection in community and primary healthcare settings.

Indexed as

Community health surveillancehypertension predictionmachine learningpopulation healthrisk stratification

Identifiers

PMID42232379
PMCPMC13225739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.